StockNews.AI
MTLS
StockNews.AI
26 days

Materialise Reports Second Quarter 2025 Results

1. Materialise's revenue fell 5.8% in Q2 2025; Medical segment grew 16.7%. 2. Overall financial performance shows mixed results impacting investor sentiment.

Earnings
-12.62%Current Return
VS
+0.44%S&P 500
$6.1807/24 06:39 AM EDTEvent Start
$5.407/25 01:15 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

While total revenue is down, the Medical segment's growth signals potential resilience, similar to historical recoveries after mixed earnings results.

How important is it?

Mixed results could influence investor decisions, highlighting the Medical segment's success against overall revenue decline.

Why Short Term?

Immediate attention may focus on recent financials, but long-term growth hinges on sustainable Medical segment success.

Related Companies

GEVODDDXONE
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2025. Highlights – Second Quarter 2025 Total consolidated revenue decreased 5.8% to 64,831 kEUR compared to the corresponding 2024 period; however at the same time our Materialise Medical segment showed a further 16.7% growth. Gross profit as a perce.

Related News